Genetic Analysis AS (XSAT:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.6400
-0.0300 (-4.48%)
At close: Mar 17, 2026

Genetic Analysis AS Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
16.7115.8914.1511.166.8
Other Revenue
4.464.89.029.586.58
21.1720.6823.1620.7513.38
Revenue Growth (YoY)
2.36%-10.71%11.65%55.08%77.51%
Cost of Revenue
4.73.324.63.911.28
Gross Profit
16.4717.3618.5716.8412.1
Selling, General & Admin
16.0616.8320.7222.3120.39
Other Operating Expenses
6.519.7816.2317.8816.05
Operating Expenses
27.7431.8542.5245.0240.97
Operating Income
-11.27-14.49-23.96-28.18-28.87
Interest Expense
-0.5-0.36-0.25-0.12-0.13
Interest & Investment Income
0.350.420.360.03-
Earnings From Equity Investments
--0.62-0.09--
Currency Exchange Gain (Loss)
-0.270.03--
Other Non Operating Income (Expenses)
0-00.09-0-
EBT Excluding Unusual Items
-11.41-14.77-23.82-28.27-29.01
Pretax Income
-11.41-14.77-23.82-28.27-29.01
Net Income
-11.41-14.77-23.82-28.27-29.01
Net Income to Common
-11.41-14.77-23.82-28.27-29.01
Shares Outstanding (Basic)
6345262525
Shares Outstanding (Diluted)
6345262525
Shares Change (YoY)
41.67%70.99%4.61%0.07%45.72%
EPS (Basic)
-0.18-0.33-0.91-1.13-1.16
EPS (Diluted)
-0.18-0.33-0.91-1.13-1.16
Free Cash Flow
2.05-8.96-17.38-19.69-27.7
Free Cash Flow Per Share
0.03-0.20-0.66-0.79-1.11
Gross Margin
77.80%83.93%80.15%81.17%90.42%
Operating Margin
-53.21%-70.03%-103.41%-135.84%-215.80%
Profit Margin
-53.91%-71.40%-102.82%-136.28%-216.80%
Free Cash Flow Margin
9.68%-43.29%-75.02%-94.88%-207.07%
EBITDA
-6.09-14.24-23.77-28-28.7
EBITDA Margin
-28.77%-68.82%-102.61%-134.95%-214.56%
D&A For EBITDA
5.170.250.190.190.17
EBIT
-11.27-14.49-23.96-28.18-28.87
EBIT Margin
-53.21%-70.03%-103.41%-135.84%-215.80%
Revenue as Reported
21.1720.6823.1620.7513.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.